Skip to main content

Zynerba Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

Zynerba Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 4,062,500 shares of its common stock at a price of $8.00 per share, for a gross deal size of $32.5 million. Stock is down 24% as a result.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.